Antibody inhibition of properdin prevents complement-mediated intravascular and extravascular hemolysis(1)

Documenti analoghi

• Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia
  di: Ueda, Yoshiyasu, et al.
  Pubblicazione: (2018)
• Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement
  di: Kimura, Yuko, et al.
  Pubblicazione: (2008)
• Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury
  di: Kimura, Yuko, et al.
  Pubblicazione: (2010)
• Blocking properdin, the alternative pathway and anaphylatoxin receptors ameliorates renal ischemia reperfusion injury in decay-accelerating factor and CD59 double knockout mice()
  di: Miwa, Takashi, et al.
  Pubblicazione: (2013)
• Properdin contributes to allergic airway inflammation through local C3a generation()
  di: Wang, Yuan, et al.
  Pubblicazione: (2015)